As a Director of Business Development, John will drive client base growth, customer relationships and marketing strategy for the Ackerman Group.  John brings over 30 years of business strategy, marketing execution and commercial leadership in both animal and human healthcare markets.  He’s held leadership positions at Covetrus, Aratana, Novartis, Boston Scientific and Covidien.  John’s expertise will play a key role in creating market demand for the Ackerman Group and establishing new client relationships to meet customer needs and exceed expectations and satisfaction.

John recently held leadership roles at Covetrus launching Atlas Pharmaceuticals, the first 503B FDA regulated compounding manufacturer in veterinary medicine, and at Aratana leading the biopharmaceutical start-up and company launch.  He has led valuation and due diligence for M&As in veterinary and human medicine and secured strategic relationships with corporate veterinary groups and e-commerce partners.  Over his career, John has launched over 30 animal health pharmaceuticals, 11 medical devices while leading numerous sales and marketing teams.

John holds a Master of Business Administration from the University of Texas and a Geophysical Engineering degree from the Colorado School of Mines. He has two children and black lab that loves a long hike up Colorado’s 14ers.